• Berk L. (2008) Systemic pilocarpine for treatment of xerostomia. Expert Opinion on Drug Metabolism and Toxicology 4, 13331340.
  • Chambers M.S., Posner M., Jones C.U., Biel M.A., Hodge K.M., Vitti R., Armstrong I., Yen C. & Weber R.S. (2007) Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. International Journal of Radiation Oncology, Biology, Physics 6884, 11021109.
  • Chitapanarux I., Kamnerdsupaphon P., Tharavichitkul E., Sumitsawan Y., Sittitrai P., Pattarasakulchai T., Lorvidhaya V., Sukthomya V., Pukanhaphan N. & Traisatit P. (2008) Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial. Journal of the Medical Association of Thailand 91, 14101415.
  • Crowe J.H., Crowe L.M., Carpenter J.F. & Aurell-Wistrom C. (1987) Stabilization of dry phospholipid bilayers and proteins by sugars. The Biochemical Journal 242, 110.
  • Davies A.N. (2000) A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliative Medicine 14, 197203.
  • Dirix P., Nuyts S., Vander Poorten V., Delaere P. & Van den Bogaert W. (2007) Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Supportive Care in Cancer 15, 14291436.
  • Epstein J.B., Tsang A.H., Warkentin D. & Ship J.A. (2002) The role of salivary function in modulating chemotherapy-induced oropharngeal mucositis: a review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 94, 3944.
  • Fisher J., Scott C., Scarantino C.W., Leveque F.G., White R.L., Rotman M., Hodson D.I., Meredith R.F., Foote R., Bachman D.G. & Lee N. (2003) Phase III quality-of-life results: impact on patients’ quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer-RTOG 97-09. International Journal of Radiation Oncology, Biology, Physics 56, 832836.
  • Gil-Montoya J.A., Guardia-López I. & González-Moles M.A. (2008) Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth – a pilot study. Gerontology 25, 39.
  • Guggenheimer J. & Moore P.A. (2003) Xerostomia etiology, recognition and treatment. The Journal of the American Dental Association 134, 6169.
  • Hahnel S., Behr M., Handel G. & Burgers R. (2009) Saliva substitutes for the treatment of radiation-induced xerostomia – a review. Supportive Care in Cancer 17, 13311343.
  • Harrold K. (2010), Effective management of adverse effects while on oral chemotherapy: implications for nursing practice. European Journal of Cancer Care 19, 1220.
  • Hong J.P., Lee S.-W., Song S.Y., Ahn S.D., Shin S.S., Choi E.K. & Kim J.H. (2009) recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies. European Journal of Cancer Care 18, 636641.
  • Jha N., Seikaly H., Harris J., Williams D., Sultanem K., Hier M., Ghosh S., Black M., Butler J., Sutherland D., Kerr P. & Barnaby P. (2009) Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head and Neck 31, 234243.
  • Matsuo T. (2007) Trehalose protects corneal epithelial cells from death by drying. The British Journal of Ophthalmology 85, 610612.
  • Mencoboni M., Grillo-Ruggieri F., Salami A., Scasso F., Rebella L., Grimaldi A., Dellepiane M., Moratti G., Bruzzone A., Spigno F., Ghio R. & Figlimeni M. (2011) Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy. European Journal of Cancer Care 20, 503507.
  • Momm F., Volegova-Heher N.J., Schulte-Monting J. & Guttenberger R. (2005) Different saliva substitutes for treatment of xerostomia following radiotherapy. Strahlentherapie und Onkologie 181, 231236.
  • Mori Y., Yano F., Shimohata N., Suzuki S., Chung U.I. & Takato T. (2010) Trehalose inhibits oral dryness by protecting the cell membrane. International Journal of Oral and Maxillofacial Surgery 39, 916921.
  • Morito A., Fujisawa K., Eguchi T. & Ota Y. (2011) Protective effects of polysaccharides and polyhydric alcohols in a dry mouth model in cultured cells. Supportive Care in Cancer 20, 725731.
  • Nakamura N., Sasano N., Yamashita H., Igaki H., Shiraishi K., Terahara A., Asakage T., Nakao K., Ebihara Y., Ohtomo K. & Nakagawa K. (2009) Oral pilocarpine (5 mg t.i.d.) used for xerostomia causes adverse effects in Japanese. Auris, Nasus, Larynx 36, 310313.
  • Potting C.M.J., Uitterhoeve R., Scholte Op Reimer W. & Van Achterberg T. (2006) The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systemic review. European Journal of Cancer Care 15, 431439.
  • Regelink G., Vissink A., Rentsema H. & Nauta J.M. (1998) Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence International 29, 383388.
  • Shahdad S.A., Taylor C., Barclay S.C., Steen I.N. & Preshaw P.M. (2005) A double-blind, crossover study of Biotene Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia. European Journal of Cancer Care 14, 319326.
  • Wick J.Y. (2007) Xerostomia: causes and treatment. The Consultant Pharmacist 22, 985992.